Successfully completed Janus Living IPO generating $966M in gross proceeds.
Operating expenses increased 18% YoY, outpacing core revenue growth.
Net income grew significantly, though heavily influenced by one-time gains.
Repurchased $100M of common stock in April 2026.
The Q1 2026 filing presents a company at a strategic crossroads, balancing aggressive structural evolution with mounting financial pressures. The Janus Living IPO is the defining event of the quarter, providing a massive liquidity injection and a new vehicle for senior housing growth. However, the immediate impact is a complex mix of accounting gains and rising operational costs that make the underlying organic growth harder to discern. Investors must weigh the success of the capital recycling strategy against the reality of a higher interest rate environment and rising expenses. While the balance sheet remains investment-grade, the proximity to debt covenants and the reliance on non-recurring gains to prop up net income introduce a layer of risk. The ultimate success of the thesis depends on whether Healthpeak can convert its recent acquisitions and the Janus Living platform into sustainable, recurring cash flow that exceeds its rising cost of capital.